APA

Joosten L. P. T., van Doorn S., Hoes A. W., Nierman M. C., Wiersma N. M., Koek H. L., Hemels M. E. W., Huisman M. V., Roes K. C., van den Bor R. M., Buding W. F., Rutten F. H. & Geersing G. (20201201). Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial. : BMJ open.

Chicago

Joosten Linda P T, van Doorn Sander, Hoes Arno W, Nierman Melchior C, Wiersma Nynke M, Koek Huiberdina L, Hemels Martin E W, Huisman Menno V, Roes Kit C, van den Bor Rutger M, Buding Wim F, Rutten Frans H and Geersing Geert-Jan. 20201201. Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial. : BMJ open.

Harvard

Joosten L. P. T., van Doorn S., Hoes A. W., Nierman M. C., Wiersma N. M., Koek H. L., Hemels M. E. W., Huisman M. V., Roes K. C., van den Bor R. M., Buding W. F., Rutten F. H. and Geersing G. (20201201). Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial. : BMJ open.

MLA

Joosten Linda P T, van Doorn Sander, Hoes Arno W, Nierman Melchior C, Wiersma Nynke M, Koek Huiberdina L, Hemels Martin E W, Huisman Menno V, Roes Kit C, van den Bor Rutger M, Buding Wim F, Rutten Frans H and Geersing Geert-Jan. Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial. : BMJ open. 20201201.